Atsushi Takenaka

Atsushi Takenaka

Auto-generated profile, based on publicly available information

Atsushi Takenaka

Division of Urology, Department of Surgery, Faculty of Medicine, Tottori University, Yonago, Japan

Research Focus & Metrics

Academic Career Length

21Years (2006-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
27 July 2021 in International Journal of Clinical Oncology
Verified
Journal Article
Closed access
PDF file
SMShuichi Morizane
Shuichi Morizane
TYTetsuya Yumioka
Tetsuya Yumioka
KMKaren Makishima
Karen Makishima
PTPanagiota Tsounapi
Panagiota Tsounapi
HIHideki Iwamoto
Hideki Iwamoto
ATAtsushi Takenaka
Atsushi Takenaka

29 October 2013 in Andrologia
Verified
Journal Article
Closed access
PDF file
CHARALAMPOS MAMOULAKISCHARALAMPOS MAMOULAKIS
CHARALAMPOS MAMOULAKIS
Ioannis GeorgiouIoannis Georgiou
Ioannis Georgiou
Fotios DimitriadisFotios Dimitriadis
Fotios Dimitriadis
PTP. Tsounapi
P. Tsounapi
IGIoannis giannakis
Ioannis giannakis
NSNikolaos Sofikitis
Nikolaos Sofikitis
This study investigated the hypothesis that genetic alterations of the human insulin-like 3 (INSL3) gene are associated with testicular maldescent (TMD). Genomic DNA was extracted and amplified from peripheral blood samples of 170 unrelated children with all possible phenotypical expressions of TMD and 50 volunteers with normal external genitalia from the general paediatric population (controls). PCR-single strand conformation polymorphism analysis was used to screen INSL3 gene for genetic variants. For rapid screening of a detected nonsilent genetic alteration, restriction assay using endonuclease Eag I was further employed. Products were analysed on 2% agarose gel and restriction patterns were visualised by ethidium bromide. Differences in genotype and allelic distributions of nonsilent genetic alterations were evaluated between (i) patients-controls, (ii) familial-sporadic, (iii) bilateral-unilateral and (iv) intra-abdominal-inguinal cases of TMD. No mutations were detected. Three common INSL3 gene polymorphisms (27G>A, 126G>A, 178G>A) unrelated to any particular phenotype of TMD were detected both in patients and controls. These results indicate that INSL3 gene mutations are not a common cause of TMD in the human.

9 September 2021 in Current Pharmaceutical Design
Verified
Journal Article
Closed access
PDF file
Fotios DimitriadisFotios Dimitriadis
Fotios Dimitriadis
Evangelos N. SymeonidisEvangelos N. Symeonidis
Evangelos N. Symeonidis
PTPanagiota Tsounapi
Panagiota Tsounapi
Aris KaltsasAris Kaltsas
Aris Kaltsas
GHGeorgios Hatzichristodoulou
Georgios Hatzichristodoulou
NSNikolaos Sofikitis
Nikolaos Sofikitis
Background & Objective: Significant advances in the field of male infertility have been witnessed during the last years. Given the well-known detrimental effects of reactive oxygen species (ROS), the administration of antioxidants has emerged as a promising solution for oxidative stress (OS)-induced male infertility. Nevertheless, this perception seems largely oversimplified, and the existing literature fails to recognize a notable superiority of the excessive use of these widely available nutritional compounds. Taking into consideration that several trials have shed light on the so-called “antioxidant paradox” phenomenon, we recognize that over-the-counter consumption of such supplements might be harmful. Method: The relevant studies indexed in PubMed, Google Scholar and Scopus databases, published until September 2019 were identified and reported. Conclusion: In this setting, we acknowledge that there is an urgent need for more elaborate studies in the future that will efficiently elucidate the risks and benefits of antioxidants on semen parameters and their impact on fertility potential.

29 October 2019 in In Vivo
Verified
Journal Article
Open access
PDF file
PTPanagiota Tsounapi
Panagiota Tsounapi
MHMasashi Honda
Masashi Honda
KHKatsuya Hikita
Katsuya Hikita
NSNikolaos Sofikitis
Nikolaos Sofikitis
ATAtsushi Takenaka
Atsushi Takenaka
Background/Aim: A short-period type 2 diabetes model was established in order to identify changes in oxidative stress in the bladder at the initiation of the disease. The effect of antioxidant treatment was examined. Materials and Methods: Diabetes was induced in adult male Wistar rats with a single dose of streptozotocin (40 mg/kg; i.p.). Diabetic animals were then randomly separated into three groups: No treatment (DM), resveratrol treatment, and taurine treatment, and fed with a high-fat diet. Age-matched non-diabetic animals were used and fed with normal diet (control). Two weeks later, animals were sacrificed and bladders were processed for histological evaluation, and further analysis for oxidative stress markers. Results: The body weight of all diabetic animals was significantly lower compared to the controls. The DM group demonstrated a significantly higher bladder weight to body weight ratio compared to the control. The bladder in the DM group demonstrated abruption of the mucosa from the muscularis and edema in the transitional epithelium. Bladders from the resveratrol-, and taurine-treated groups did not demonstrate these histological alterations. The level of malondialdehyde (MDA) in the bladder was significantly higher in the DM group compared to all other groups. Immunohistochemistry showed that diabetes induced a moderate to strong expression of oxidative stress markers MDA and 4-hydroxynonenal, and DNA oxidative stress marker 8-deoxyguanosine in the DM group compared to the other groups. Conclusion: Prompt diagnosis and treatment of diabetes is crucial in regard to disease progression. Specifically, in the bladder it appears that both mild damage at the structural level, as well as oxidative damage at the molecular level may be prevented by antioxidant treatment.

4 March 2013 in Reproductive BioMedicine Online
Verified
Journal Article
Closed access
PDF file
LLLeandros Lazaros
Leandros Lazaros
GVGeorge Vartholomatos
George Vartholomatos
CPChristina Pamporaki
Christina Pamporaki
IKIoannis Kosmas
Ioannis Kosmas
ATAtsushi Takenaka
Atsushi Takenaka
Ioannis GeorgiouIoannis Georgiou
Ioannis Georgiou

19 April 2018 in International Journal of Urology
Verified
Journal Article
Open access
PDF file
KTKazushi Tanaka
Kazushi Tanaka
JTJun Teishima
Jun Teishima
ATAtsushi Takenaka
Atsushi Takenaka
RSRyoichi Shiroki
Ryoichi Shiroki
YKYasuyuki Kobayashi
Yasuyuki Kobayashi
MFMasato Fujisawa
Masato Fujisawa
Objectives: To evaluate the outcomes of robotic partial nephrectomy compared with those of laparoscopic partial nephrectomy for T1 renal tumors in Japanese centers.Methods: Patients with a T1 renal tumor who underwent robotic partial nephrectomy were eligible for inclusion in the present study. The primary end‐point consisted of three components: a negative surgical margin, no conversion to open or laparoscopic surgery and a warm ischemia time ≤25 min. We compared data from these patients with the data from a retrospective study of laparoscopic partial nephrectomy carried out in Japan.Results: A total of 108 patients were registered in the present study; 105 underwent robotic partial nephrectomy. The proportion of patients who met the primary end‐point was 91.3% (95% confidence interval 84.1–95.9%), which was significantly higher than 23.3% in the historical data. Major complications were seen in 19 patients (18.1%). The mean change in the estimated glomerular filtration rate in the operated kidney, 180 days postoperatively, was −10.8 mL/min/1.73 m2 (95% confidence interval −12.3–9.4%).Conclusions: Robotic partial nephrectomy for patients with a T1 renal tumor is a safe, feasible and more effective operative method compared with laparoscopic partial nephrectomy. It can be anticipated that robotic partial nephrectomy will become more widely used in Japan in the future.